文献速递慢性肾脏病肾小球疾病遗传性与小管间质肾病

ALG8与ALG9单等位基因致病性变异相关囊性表型特征

Characterization of the Cystic Phenotype Associated with Monoallelic ALG8 and ALG9 Pathogenic Variants.
PubMed 文献 · J Am Soc Nephrol · 2025-02-03

本研究筛查超过3900个囊性肾病/肝病家族及三个人群队列,发现ALG8和ALG9致病性变异在囊性肾/肝病人群中富集,频率分别约为非囊性肾病对照的10倍和24倍。ALG8和ALG9相关肾脏表型通常为轻至中度,eGFR降低或肾衰竭罕见,但ALG8变异有时导致严重多囊肝病。

要点

  • ALG8和ALG9致病性变异在囊性肾/肝病人群中富集,支持其为囊性肾病/肝病基因。
  • ALG8和ALG9相关肾脏表型多为轻至中度,eGFR降低或肾衰竭罕见。
  • ALG8变异可导致严重多囊肝病,部分患者肝脏显著增大。

核心结论

  • ALG8和ALG9被定义为囊性肾/肝病基因,但外显率有限,eGFR降低罕见。

研究设计与样本

  • 多中心筛查超过3900个囊性肾和/或肝病家族,使用全局方法检测ALG8或ALG9致病性变异。
  • 在Genomics England 100K Genomics Project、UK Biobank和Mayo Clinic Biobank三个人群队列中筛查ALG8/ALG9致病性变异。

主要发现

  • 多中心筛查发现51个(1.3%)ALG8家族(7个多重)和23个(0.6%)ALG9家族(5个多重),频率分别约为非多囊肾病对照的10倍和24倍。
  • 在100K Genomics Project、UK Biobank和MCBB的多囊肾表型个体中,分别发现9个(0.39%)ALG8和9个(0.39%)ALG9家族,频率高于对照。
  • ALG8突变个体通常表现为轻度囊性肾脏伴有限增大,肝囊肿常见(71%),62例中11例肝脏增大(>2L),但手术干预罕见;ALG9肾脏表型亦为轻度囊性肾脏,肝脏增大罕见;两基因相关CKD或肾衰竭均罕见。

关键数值与推荐

  • ALG8致病性变异家族频率1.3%(51/3900余),约为非多囊肾病对照的10倍。
  • ALG9致病性变异家族频率0.6%(23/3900余),约为非多囊肾病对照的24倍。
  • 人群队列多囊肾表型个体中ALG8和ALG9家族频率均为0.39%(各9个家族)。
  • ALG8突变个体肝囊肿常见(71%),62例中11例肝脏>2L,手术干预罕见。

临床怎么用

  • 对囊性肾病/肝病患者可考虑ALG8和ALG9基因检测,尤其当肾脏表型轻至中度且无肾衰竭时。
  • ALG8变异患者应评估肝囊肿和肝脏增大,尽管手术干预罕见。
  • ALG8/ALG9相关囊性肾病通常进展缓慢,eGFR降低罕见,预后咨询可相应参考。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: Loss-of-function ALG8 and ALG9 variants were enriched in polycystic kidney/liver groups and International Classification of Diseases–coded cystic individuals in population cohorts. The ALG8 and ALG9 kidney phenotypes were usually mild to moderate, and lower eGFR or kidney failure was rare. ALG8 pathogenic variants sometimes resulted in severe polycystic liver disease. BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is a common, inherited nephropathy often resulting in kidney failure. It is genetically heterogeneous; along with the major genes, PKD1 and PKD2, at least eight others have been suggested. ALG8 pathogenic variants have been associated with autosomal dominant polycystic liver disease and implicated in ADPKD, while ALG9 has been suggested as an ADPKD gene, but details of the phenotypes and penetrance are unclear. METHODS: We screened >3900 families with cystic kidneys and/or livers using global approaches to detect ALG8 or ALG9 pathogenic variants. In addition, population cohorts with sequence data (Genomics England 100K Genomics Project, UK Biobank, and Mayo Clinic Biobank [MCBB]) were screened for ALG8/ALG9 pathogenic variants. RESULTS: Multicenter screening of individuals with polycystic kidney and/or liver disease identified 51 (1.3%) ALG8 (7 multiplex) and 23 (0.6%) ALG9 (5 multiplex) families—frequencies that were approximately 10× and approximately 24× greater than nonpolycystic kidney disease controls. Analysis of individuals with polycystic kidney disease phenotypes in 100K Genomics Project, UK Biobank, and MCBB identified nine ALG8 (0.39%) and nine ALG9 (0.39%) families, an enriched frequency over controls. Two individuals had PKD1 and ALG8 pathogenic changes. Eighty-nine percent of individuals with ALG8 mutations with imaging in the entire MCBB had kidney cysts (50%, >10 cysts), with greater median kidney and liver cyst numbers than controls. For ALG9, 78% had kidney cysts (27%, >10 cysts). Individuals with ALG8 mutations typically had mild cystic kidneys with limited enlargement. Liver cysts were common (71%), with enlarged livers (>2L) found in 11 of 62 patients, although surgical intervention was rare. The ALG9 kidney phenotype was also of mild cystic kidneys, but enlarged livers were rare; for both genes, CKD or kidney failure were rare. CONCLUSIONS: ALG8 and ALG9 are defined as cystic kidney/liver genes but with limited penetrance for lower eGFR.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Jawaid T, Elbarougy DE, Lavu S, et al. Characterization of the Cystic Phenotype Associated with Monoallelic ALG8 and ALG9 Pathogenic Variants. J Am Soc Nephrol. 2025. PMID: 39899384. doi:10.1681/ASN.0000000613

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。